Financhill
Sell
33

ARAY Quote, Financials, Valuation and Earnings

Last price:
$1.56
Seasonality move :
-2.34%
Day range:
$1.57 - $1.62
52-week range:
$1.28 - $2.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.35x
P/B ratio:
3.28x
Volume:
375.5K
Avg. volume:
690.6K
1-year change:
3.27%
Market cap:
$162.8M
Revenue:
$446.6M
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ARAY
Accuray
$101.5M -$0.05 -7.83% -55.57% $5.63
BSX
Boston Scientific
$4.6B $0.67 18.78% 229.2% $116.96
CATX
Perspective Therapeutics
$143.9K -$0.27 -- -55.87% $13.8214
ITGR
Integer Holdings
$428.7M $1.24 6.46% 76.23% $148.75
VNRX
VolitionRX
$1.1M -$0.05 7.51% -40.63% $2.92
XTNT
Xtant Medical Holdings
$31.2M -$0.01 4.73% -33.33% $1.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ARAY
Accuray
$1.58 $5.63 $162.8M -- $0.00 0% 0.35x
BSX
Boston Scientific
$104.50 $116.96 $154.6B 76.28x $0.00 0% 8.86x
CATX
Perspective Therapeutics
$2.5100 $13.8214 $186.3M -- $0.00 0% 17.69x
ITGR
Integer Holdings
$118.16 $148.75 $4.1B 56.00x $0.00 0% 2.38x
VNRX
VolitionRX
$0.52 $2.92 $53.3M -- $0.00 0% 35.63x
XTNT
Xtant Medical Holdings
$0.73 $1.75 $101.2M -- $0.00 0% 0.81x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ARAY
Accuray
77.8% 2.284 94.39% 0.82x
BSX
Boston Scientific
33.49% 1.029 7.48% 0.68x
CATX
Perspective Therapeutics
-- -1.032 -- --
ITGR
Integer Holdings
43.46% 1.567 30% 1.99x
VNRX
VolitionRX
-29.91% 1.111 11.38% 0.34x
XTNT
Xtant Medical Holdings
43.24% -0.806 51.14% 0.96x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ARAY
Accuray
$31.6M $1M 0.31% 1.47% 1.81% $15.6M
BSX
Boston Scientific
$3.2B $937M 6.35% 9.57% 19.02% $277M
CATX
Perspective Therapeutics
-- -$21.8M -- -- -- -$26.2M
ITGR
Integer Holdings
$120.3M $55.8M 2.85% 4.85% -0.02% $6.1M
VNRX
VolitionRX
-- -$5.4M -- -- -2183.56% -$4.3M
XTNT
Xtant Medical Holdings
$20.2M $1.1M -15.44% -26.62% 3.28% $87K

Accuray vs. Competitors

  • Which has Higher Returns ARAY or BSX?

    Boston Scientific has a net margin of -1.15% compared to Accuray's net margin of 14.45%. Accuray's return on equity of 1.47% beat Boston Scientific's return on equity of 9.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ARAY
    Accuray
    27.93% -$0.01 $223.4M
    BSX
    Boston Scientific
    68.84% $0.45 $33.6B
  • What do Analysts Say About ARAY or BSX?

    Accuray has a consensus price target of $5.63, signalling upside risk potential of 256.01%. On the other hand Boston Scientific has an analysts' consensus of $116.96 which suggests that it could grow by 11.93%. Given that Accuray has higher upside potential than Boston Scientific, analysts believe Accuray is more attractive than Boston Scientific.

    Company Buy Ratings Hold Ratings Sell Ratings
    ARAY
    Accuray
    3 0 0
    BSX
    Boston Scientific
    23 3 0
  • Is ARAY or BSX More Risky?

    Accuray has a beta of 1.304, which suggesting that the stock is 30.444% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.685, suggesting its less volatile than the S&P 500 by 31.536%.

  • Which is a Better Dividend Stock ARAY or BSX?

    Accuray has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Accuray pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ARAY or BSX?

    Accuray quarterly revenues are $113.2M, which are smaller than Boston Scientific quarterly revenues of $4.7B. Accuray's net income of -$1.3M is lower than Boston Scientific's net income of $674M. Notably, Accuray's price-to-earnings ratio is -- while Boston Scientific's PE ratio is 76.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Accuray is 0.35x versus 8.86x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ARAY
    Accuray
    0.35x -- $113.2M -$1.3M
    BSX
    Boston Scientific
    8.86x 76.28x $4.7B $674M
  • Which has Higher Returns ARAY or CATX?

    Perspective Therapeutics has a net margin of -1.15% compared to Accuray's net margin of --. Accuray's return on equity of 1.47% beat Perspective Therapeutics's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ARAY
    Accuray
    27.93% -$0.01 $223.4M
    CATX
    Perspective Therapeutics
    -- -$0.25 --
  • What do Analysts Say About ARAY or CATX?

    Accuray has a consensus price target of $5.63, signalling upside risk potential of 256.01%. On the other hand Perspective Therapeutics has an analysts' consensus of $13.8214 which suggests that it could grow by 450.66%. Given that Perspective Therapeutics has higher upside potential than Accuray, analysts believe Perspective Therapeutics is more attractive than Accuray.

    Company Buy Ratings Hold Ratings Sell Ratings
    ARAY
    Accuray
    3 0 0
    CATX
    Perspective Therapeutics
    10 1 0
  • Is ARAY or CATX More Risky?

    Accuray has a beta of 1.304, which suggesting that the stock is 30.444% more volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.112, suggesting its more volatile than the S&P 500 by 11.175%.

  • Which is a Better Dividend Stock ARAY or CATX?

    Accuray has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Accuray pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ARAY or CATX?

    Accuray quarterly revenues are $113.2M, which are larger than Perspective Therapeutics quarterly revenues of --. Accuray's net income of -$1.3M is higher than Perspective Therapeutics's net income of -$18.2M. Notably, Accuray's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Accuray is 0.35x versus 17.69x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ARAY
    Accuray
    0.35x -- $113.2M -$1.3M
    CATX
    Perspective Therapeutics
    17.69x -- -- -$18.2M
  • Which has Higher Returns ARAY or ITGR?

    Integer Holdings has a net margin of -1.15% compared to Accuray's net margin of -5.14%. Accuray's return on equity of 1.47% beat Integer Holdings's return on equity of 4.85%.

    Company Gross Margin Earnings Per Share Invested Capital
    ARAY
    Accuray
    27.93% -$0.01 $223.4M
    ITGR
    Integer Holdings
    27.51% -$0.66 $2.8B
  • What do Analysts Say About ARAY or ITGR?

    Accuray has a consensus price target of $5.63, signalling upside risk potential of 256.01%. On the other hand Integer Holdings has an analysts' consensus of $148.75 which suggests that it could grow by 25.89%. Given that Accuray has higher upside potential than Integer Holdings, analysts believe Accuray is more attractive than Integer Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ARAY
    Accuray
    3 0 0
    ITGR
    Integer Holdings
    7 1 0
  • Is ARAY or ITGR More Risky?

    Accuray has a beta of 1.304, which suggesting that the stock is 30.444% more volatile than S&P 500. In comparison Integer Holdings has a beta of 1.030, suggesting its more volatile than the S&P 500 by 3.045%.

  • Which is a Better Dividend Stock ARAY or ITGR?

    Accuray has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integer Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Accuray pays -- of its earnings as a dividend. Integer Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ARAY or ITGR?

    Accuray quarterly revenues are $113.2M, which are smaller than Integer Holdings quarterly revenues of $437.4M. Accuray's net income of -$1.3M is higher than Integer Holdings's net income of -$22.5M. Notably, Accuray's price-to-earnings ratio is -- while Integer Holdings's PE ratio is 56.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Accuray is 0.35x versus 2.38x for Integer Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ARAY
    Accuray
    0.35x -- $113.2M -$1.3M
    ITGR
    Integer Holdings
    2.38x 56.00x $437.4M -$22.5M
  • Which has Higher Returns ARAY or VNRX?

    VolitionRX has a net margin of -1.15% compared to Accuray's net margin of -2201.34%. Accuray's return on equity of 1.47% beat VolitionRX's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ARAY
    Accuray
    27.93% -$0.01 $223.4M
    VNRX
    VolitionRX
    -- -$0.06 -$22.6M
  • What do Analysts Say About ARAY or VNRX?

    Accuray has a consensus price target of $5.63, signalling upside risk potential of 256.01%. On the other hand VolitionRX has an analysts' consensus of $2.92 which suggests that it could grow by 465.68%. Given that VolitionRX has higher upside potential than Accuray, analysts believe VolitionRX is more attractive than Accuray.

    Company Buy Ratings Hold Ratings Sell Ratings
    ARAY
    Accuray
    3 0 0
    VNRX
    VolitionRX
    2 1 0
  • Is ARAY or VNRX More Risky?

    Accuray has a beta of 1.304, which suggesting that the stock is 30.444% more volatile than S&P 500. In comparison VolitionRX has a beta of 0.997, suggesting its less volatile than the S&P 500 by 0.339%.

  • Which is a Better Dividend Stock ARAY or VNRX?

    Accuray has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Accuray pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ARAY or VNRX?

    Accuray quarterly revenues are $113.2M, which are larger than VolitionRX quarterly revenues of $246.4K. Accuray's net income of -$1.3M is higher than VolitionRX's net income of -$5.4M. Notably, Accuray's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Accuray is 0.35x versus 35.63x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ARAY
    Accuray
    0.35x -- $113.2M -$1.3M
    VNRX
    VolitionRX
    35.63x -- $246.4K -$5.4M
  • Which has Higher Returns ARAY or XTNT?

    Xtant Medical Holdings has a net margin of -1.15% compared to Accuray's net margin of 0.18%. Accuray's return on equity of 1.47% beat Xtant Medical Holdings's return on equity of -26.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    ARAY
    Accuray
    27.93% -$0.01 $223.4M
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
  • What do Analysts Say About ARAY or XTNT?

    Accuray has a consensus price target of $5.63, signalling upside risk potential of 256.01%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 140.88%. Given that Accuray has higher upside potential than Xtant Medical Holdings, analysts believe Accuray is more attractive than Xtant Medical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ARAY
    Accuray
    3 0 0
    XTNT
    Xtant Medical Holdings
    2 0 0
  • Is ARAY or XTNT More Risky?

    Accuray has a beta of 1.304, which suggesting that the stock is 30.444% more volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.124, suggesting its less volatile than the S&P 500 by 112.425%.

  • Which is a Better Dividend Stock ARAY or XTNT?

    Accuray has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Accuray pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ARAY or XTNT?

    Accuray quarterly revenues are $113.2M, which are larger than Xtant Medical Holdings quarterly revenues of $32.9M. Accuray's net income of -$1.3M is lower than Xtant Medical Holdings's net income of $58K. Notably, Accuray's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Accuray is 0.35x versus 0.81x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ARAY
    Accuray
    0.35x -- $113.2M -$1.3M
    XTNT
    Xtant Medical Holdings
    0.81x -- $32.9M $58K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Cognizant Stock Be In 5 Years?
Where Will Cognizant Stock Be In 5 Years?

Cognizant Technologies (NASDAQ:CTSH) is a global provider of IT services…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) are two of the hottest…

Why Did Forge Global Stock Go Down?
Why Did Forge Global Stock Go Down?

Shares of Forge Global (NYSE:FRGE), a platform that allows accredited…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
66
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
54
AAP alert for May 23

Advance Auto Parts [AAP] is down 0.98% over the past day.

Buy
67
IONQ alert for May 23

IonQ [IONQ] is down 0.48% over the past day.

Buy
75
URBN alert for May 23

Urban Outfitters [URBN] is down 1.24% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock